Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions.

Area of Science:

• Genetics and Genomics
• Cancer Biology
• Molecular Diagnostics

Background:

• BRCA1 is a critical gene for breast and ovarian cancer susceptibility.
• Pathogenic variants in BRCA1 include protein-truncating mutations and missense substitutions.
• Known pathogenic missense substitutions are concentrated in the RING and BRCT domains, affecting protein function.

Purpose of the Study:

• To systematically assess the pathogenicity of all possible BRCA1 RING domain missense substitutions.
• To evaluate the functional impact of these substitutions on BARD1 heterodimerization.
• To develop a clinically applicable classification system for BRCA1 missense variants.

Main Methods:

• Utilized a mammalian two-hybrid assay to test BRCA1 RING domain missense substitutions for BARD1 heterodimerization.
• Employed assay calibration and validation strategies.
• Integrated functional assay data with computational predictions and human observational data using a Bayesian point system.

Main Results:

• Identified 15%-20% of BRCA1 RING domain missense substitutions as pathogenic.
• Achieved clinical classification for 89% of observed missense substitutions.
• Identified additional variants with strong evidence for pathogenicity or benignity based on functional and computational data.

Conclusions:

• Functional assessment of BRCA1 RING domain missense substitutions is vital for understanding cancer risk.
• A combined approach integrating functional assays, computational data, and observational data enhances variant classification accuracy.
• This framework improves the clinical interpretation of BRCA1 variants, aiding in genetic counseling and risk assessment for hereditary breast and ovarian cancer.